Triäthylenmelamin (Tem), ein neuer Stoff zur Behandlung von Leukämien

Publisher Website

1 June 1952

journal article
Published by Springer Nature in Klinische Wochenschrift

Vol. 30 (23-24), 537-547
https://doi.org/10.1007/bf01472179

Abstract

No abstract available

Keywords

LEUKEMIA/THERAPY

This publication has 3 references indexed in Scilit:

New Cytotoxic Agents with Tumour-Inhibitory Activity
Nature, 1950
Triethylene melamine in the treatment of Hodgkin's disease and allied neoplasms.
1950
RETARDATION OF TUMOR GROWTH IN MICE BY ORAL ADMINISTRATION OF ETHYLENIMINE DERIVATIVES
1950

Cited by 8 articles